Congratulations to Geneva University, the EPAD Trial Delivery Centre of the Month

We are delighted to announce that April was the most successful month to date with 73 new research participants enrolled in the EPAD Longitudinal Cohort Study. We continued the positive trend in recruitment of research participants by exceeding the 66 research participants enrolled in March and the 53 in February. Congratulations are due to Université de Genève (Geneva,…

Interview with Sarah Gregory

What is your current role in EPAD? I coordinate EPAD at the Edinburgh Trial Delivery Centre, working with a great team of research assistants, study doctors and research nurses to deliver the protocol. I oversee the daily running of the study in our TDC, making sure we have sufficient recruitment avenues to bring in new…

EPAD has new TDCs on board

The first quarter of 2018 started with great intensity! We were busy working towards opening new sites and improving recruitment. Positive results of our work have begun to come out in a short time with specific progress achieved. First of all, we are delighted to have reached a big milestone in February 2018 when our…

Interview with Harry Peaker

What is your current role in EPAD? As a Data Scientist at Aridhia, I support the development and maintenance of the Analytical Database for the EPAD Longitudinal Cohort Study. IQVIA securely transfer the collated project data from their EDC platform (Medidata Rave) to our digital research platform (AnalytiXagility) on a regular basis. We transform the…

EPAD publishes a paper in the Journal of Sociology of Health & Illness

Summary: Biomedical research aimed at the development of therapies for chronic and late‐onset conditions increasingly concentrates on the early treatment of symptom‐less disease. This broad trend is evidenced in prominent shifts in contemporary dementia research. Revised diagnostic criteria and new approaches to clinical trials propose a focus on earlier stages of disease and prompt concerns…

WP3 EPAD Registry paper in Alzheimer’s & Dementia

ABSTRACT: Introduction: It is a challenge to find participants for Alzheimer’s disease (AD) prevention trials within a short period of time. The European Prevention of Alzheimer’s Dementia Registry (EPAD) aims to facilitate recruitment by preselecting subjects from ongoing cohort studies. This article introduces this novel approach. Methods: A virtual registry, with access to risk factors…

EPAD is glad to be featured in The Lancet Neurology

On 22 March, The Lancet Neurology published an article entitled: “Frederik Barkhof: building bridges between disciplines” where EPAD and its sister project AMYPAD were featured. In this great article, Professor Frederik Barkhof, AMYPAD coordinator and member of the EPAD imaging scientific advisory group, was interviewed to share his early academic journey. The article can be downloaded…